Predictive Power of Demographic and Clinicopathological Aspects of Patients with Acral Melanoma: a Single-Center Series Of 394 Cases in Brazil

Authors

DOI:

https://doi.org/10.32635/2176-9745.RBC.2023v69n4.4412

Keywords:

melanoma, hand-foot syndrome, survival, prognosis

Abstract

Introduction: Acral melanoma (AM) is associated with high mortality and poor survival, and its prognosis is worse compared to other melanoma subtypes. Objective: To analyze the predictive power of demographic and clinicopathological aspects in patients with AM. Method: This is a retrospective study with patients diagnosed with AM between January 2001 and December 2015. Demographic and clinicopathological characteristics were collected. The outcome was 5-year overall survival (OS). Kaplan-Meier curves, log rank-test and Cox regression analysis were used. Results: The study identified 394 patients with AM. The 5-year survival rate for patients with AM was found to be 45.6%. The predictive factors of OS included Breslow thickness [hazard ratio (HR): 1.02, 95% confidence interval (CI): 1.01-1.03], ulceration (HR: 4.06, 95%CI: 2.18-7.57) and lymphovascular invasion (LVI) (HR: 2.12, 95%CI:1.12-4.00). Conclusion: The findings highlight the poor prognosis of AM and the predictive power of Breslow thickness, ulceration and LVI.

Downloads

Download data is not yet available.

References

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34. DOI: https://doi.org/10.3322/caac.21551

Reed RJ. New concepts in surgical pathology of the skin. In: Hartmann W, Kay S, Reed RJ, editors. Histopatogy. New York: John Wiley & Sons; 1976.

Bradford PT, Goldstein AM, McMaster ML, et al. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol. 2009;145(4):427-34. DOI: https://doi.org/10.1001/archdermatol.2008.609

Bristow I, Bower C. Melanoma of the foot. Clin Podiatr Med Surg. 2016;33(3):409-22. DOI: https://doi.org/10.1016/j.cpm.2016.02.008

Markovic SN, Erickson LA, Rao RD, et al. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc. 2007;82(4):490-513. DOI: https://doi.org/10.4065/82.4.490

Piliang MP. Acral lentiginous melanoma. Clin Lab Med. 2011;31(2):281-8. DOI: https://doi.org/10.1016/j.cll.2011.03.005

Green A, McCredie M, MacKie R, et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control. 1999;10(1):21-5. DOI: https://doi.org/10.1023/A:1008872014889

Phan A, Touzet S, Dalle S, et al. Acral lentiginous melanoma: histopathological prognostic features of 121 cases. Br J Dermatol. 2007;157(2):311-8. DOI: https://doi.org/10.1111/j.1365-2133.2007.08031.x

Rolón PA, Kramárová E, Rolón HI, et al. Plantar melanoma: a case-control study in Paraguay. Cancer Causes Control. 1997;8(6):850-6. DOI: https://doi.org/10.1023/A:1018460227927

Kuchelmeister C, Schaumburg-Lever G, Garbe C. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol. 2000;143(2):275-80. DOI: https://doi.org/10.1046/j.1365-2133.2000.03651.x

Pollack LA, Li J, Berkowitz Z, et al. Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol. 2011;65(5 Supl 1):S78-86. DOI: https://doi.org/10.1016/j.jaad.2011.05.030

Slingluff CL, Vollmer R, Seigler HF. Acral melanoma: a review of 185 patients with identification of prognostic variables. J Surg Oncol. 1990;45(2):91-8. DOI: https://doi.org/10.1002/jso.2930450207

Nunes LF, Quintella Mendes GL, Koifman RJ. Acral melanoma: a retrospective cohort from the Brazilian National Cancer Institute (INCA). Melanoma Res. 2018;28(5):458-64. DOI: https://doi.org/10.1097/CMR.0000000000000476

O’Leary JA, Berend KR, Johnson JL, et al. Subungual melanoma. A review of 93 cases with identification of prognostic variables. Clin Orthop Relat Res. 2000;(378):206-12. DOI: https://doi.org/10.1097/00003086-200009000-00031

Fitzpatrick TB. Enigma of the pathogenesis of primary melanoma: changing incidence and mortality in Japan and the United States. J Invest Dermatol. 1989;92(5 Supl):234S-5S. DOI: https://doi.org/10.1111/1523-1747.ep13075615

Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902-8. DOI: https://doi.org/10.1097/00000658-197011000-00017

Clark WH, From L, Bernardino EA, et al. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29(3):705-27.

Gershenwald JE, Scolyer RA. Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond. Ann Surg Oncol. 2018;25(8):2105-10. DOI: https://doi.org/10.1245/s10434-018-6513-7

Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472-92. DOI: https://doi.org/10.3322/caac.21409

Conselho Nacional de Saúde (BR). Resolução n° 466, de 12 de dezembro de 2012. Aprova as diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, Brasília, DF. 2013 jun 13; Seção I:59.

Bello DM, Chou JF, Panageas KS, et al. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol. 2013;20(11):3618-25. DOI: https://doi.org/10.1245/s10434-013-3089-0

Cascinelli N, Zurrida S, Galimberti V, et al. Acral lentiginous melanoma. A histological type without prognostic significance. J Dermatol Surg Oncol. 1994;20(12):817-22. DOI: https://doi.org/10.1111/j.1524-4725.1994.tb03711.x

Fortin PT, Freiberg AA, Rees R, et al. Malignant melanoma of the foot and ankle. J Bone Joint Surg Am. 1995;77(9):1396-403. DOI: https://doi.org/10.2106/00004623-199509000-00016

Scrivner D, Oxenhandler RW, Lopez M, et al. Plantar lentiginous melanoma. A clinicopathologic study. Cancer. 1987;60(10):2502-9. DOI: https://doi.org/10.1002/1097-0142(19871115)60:10<2502::AID-CNCR2820601026>3.0.CO;2-V

Collins KK, Fields RC, Baptiste D, et al. Racial differences in survival after surgical treatment for melanoma. Ann Surg Oncol. 2011;18(10):2925-36. DOI: https://doi.org/10.1245/s10434-011-1706-3

Krementz ET, Feed RJ, Coleman WP, et al. Acral lentiginous melanoma. a clinicopathologic entity. Ann Surg. 1982;195(5):632-45. DOI: https://doi.org/10.1097/00000658-198205000-00013

Finley RK, Driscoll DL, Blumenson LE, et al. Subungual melanoma: an eighteen-year review. Surgery. 1994;116(1):96-100.

Kato T, Suetake T, Tabata N, et al. Epidemiology and prognosis of plantar melanoma in 62 japanese patients over a 28-year period. Int J Dermatol. 1999;38(7):515-9. DOI: https://doi.org/10.1046/j.1365-4362.1999.00736.x

Lv J, Dai B, Kong Y, et al. Acral Melanoma in Chinese: a clinicopathological and prognostic study of 142 cases. Sci Rep. 2016;6:31432. DOI: https://doi.org/10.1038/srep31432

Seiji M, Takematsu H, Hosokawa M, et al. Acral melanoma in Japan. J Invest Dermatol. 1983;80(Supl):56s-60s. DOI: https://doi.org/10.1111/1523-1747.ep12537212

Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199-206. DOI: https://doi.org/10.1200/JCO.2009.23.4799

Crompton JG, Gilbert E, Brady MS. Clinical implications of the eighth edition of the American Joint Committee on Cancer melanoma staging. J Surg Oncol. 2019;119(2):168-74. DOI: https://doi.org/10.1002/jso.25343

Gershenwald JE, Ross MI. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med. 2011;364(18):1738-45. DOI: https://doi.org/10.1056/NEJMct1002967

Maduekwe UN, Hornicek FJ, Springfield DS, et al. Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas. Annals of Surgical Oncology. 2009;16(5):1356-63. DOI: https://doi.org/10.1245/s10434-009-0393-9

Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599-609. DOI: https://doi.org/10.1056/NEJMoa1310460

Egger ME, Gilbert JE, Burton AL, et al. Lymphovascular invasion as a prognostic factor in melanoma. Am Surg. 2011;77(8):992-7. DOI: https://doi.org/10.1177/000313481107700816

Downloads

Published

2024-01-10

How to Cite

1.
Nunes LF, Oliveira LC, Mendes GLQ, Wainstain AJA, Thuler LCS, Bergmann A. Predictive Power of Demographic and Clinicopathological Aspects of Patients with Acral Melanoma: a Single-Center Series Of 394 Cases in Brazil . Rev. Bras. Cancerol. [Internet]. 2024 Jan. 10 [cited 2024 May 15];69(4):e-234412. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/4412

Issue

Section

ORIGINAL ARTICLE

Most read articles by the same author(s)

1 2 3 4 > >>